戻る Agenda
[V1-S6] What Information and Communication Do Patients Want in Clinical Trials? How We Can Provide Them? (Part 2)
Session Chair(s)
Yasuhiro Fujiwara, MD, PHD
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshikata Furuya, MSC
Manager, General Affairs Division, Sankeien Hoshoukai Foundation, Japan
In order to engage patients as a partner in drug development and promote their involvement, it is important to understand patients’ needs in information and communication in clinical trials then provide them to patients. Disclosure of clinical trial information and provision of lay summaries of clinical trial results are beginning to be carried out in Japan. This session aims to understand what information and communication patients are seeking before, during and after clinical trials, and discuss how we should provide them to patients based on the regulations and case studies in Japan and global. In part 2 session, status in EU on patient communication will be stared and all speakers of part 1 and 2 sessions will have a panel discussion.
Speaker(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs, European Medicines Agency, Netherlands
Efforts and Status in EU on Patient Communication and Information Sharing in Clinical Trials
Iris Loew-Friedrich, DrMed
Executive Vice President and Chief Medical Officer, UCB SA, Belgium
Industry’s Efforts on Patient Communication and Information Sharing in Clinical Trials in EU
Kazuhiko Mori, PHD, MSC
Business Manager, "Toyama, the Silicon Valley of Medicine" Creative Consortium Management Office, Japan